Functional and prognostic significance of the genomic amplification of frizzled 6 (<i><scp>FZD6</scp></i>) in breast cancerGabriele Corda, Arturo Sala, Gianluca Sala et al.|The Journal of Pathology|2016Cited by 74
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast CancerKalnisha Naidoo, Rachael Natrajan, Paul M. Moseley et al.|Molecular Cancer Therapeutics|2018Cited by 68
Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancerNirmesh Patel, Andrew Tutt, Daniel Weekes et al.|Nature Communications|2018Cited by 57
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with EribulinGwo‐Yaw Ho, Holly E. Barker, Elizabeth L. Kyran et al.|Cancer Research|2022Cited by 26
Abstract 67: An integrated copy number and gene expression genomics analysis and RNAi approach identifies and validates the KIFC1 kinesin as a malignant cell selective target in triple negative breast cancerNirmesh Patel, Andrew Tutt, Κωνσταντίνος Δροσόπουλος et al.|Cancer Research|2016Cited by 0